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ABSTRACT 35 
Background and aims: a healthy diet is recommended for the prevention of coronary artery disease 36 
(CAD), but whereas patients with CAD adhere to a healthy diet is unclear. We aimed to assess the 37 
impact of a CAD event on dietary intake. 38 
Methods: prospective, population-based, observational study conducted between 2009 and 2017. 39 
Dietary intake was assessed using a validated food frequency questionnaire. Three comparisons were 40 
performed: 1) between participants with history of CAD and gender- and age-matched controls; 2) 41 
before and after the occurrence of a CAD event, and 3) between participants with an incident CAD 42 
event and gender- and age-matched controls. 43 
Results: in analysis 1), after multivariable adjustment, participants with history of CAD had a lower 44 
total energy intake than controls (adjusted mean±standard error: 1833±36 vs. 1940±26 kcal/day, 45 
p=0.022), while no difference was found for all other dietary markers. In analysis 2) (n=87) total 46 
energy intake increased (1927±593 vs. 2100±700 kcal/day before and after the event, respectively, 47 
p=0.029) and prevalence of low fat diet decreased (35.6% vs. 21.8%, p=0.036), while no difference 48 
was found for all other dietary markers. In analysis 3), participants with incident CAD had higher 49 
vegetable protein intake (adjusted mean±standard error 4.8±0.1 vs. 4.5±0.1% of total energy intake, 50 
p=0.028), AHEI score (34±1 vs. 31±1, p=0.032), and complied more frequently with vegetables 51 
guidelines [odds ratio and 95% confidence interval; 7.64 (1.06-55.2)] than controls, while no 52 
differences were found for all other dietary markers 53 
Conclusions: in Switzerland, secondary prevention of CAD by diet is seldom implemented. 54 
Abstract word count: 247 55 
Keywords: prospective study; secondary prevention; coronary artery disease; diet; dietary 56 
guidelines. 57 
58 
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INTRODUCTION 59 
Patients who present with nonfatal cardiovascular disease (CVD)(i.e. coronary artery disease 60 
(CAD) or stroke) are urged to adopt healthy lifestyles to prevent recurrence of disease [1]. Such 61 
lifestyles include the absence of smoking, a healthy diet [2] and increasing physical activity [3, 4]. 62 
Adequate rehabilitation after a CHD event reduces mortality and recurrent events [5-7], however, 63 
the reduction in mortality appears to be restricted to before-after studies [8]. Guidelines regarding 64 
the secondary prevention of CAD [9] and stroke [10] have been issued. Still, it has been estimated 65 
that less than one third of patients with CVD does not benefit from rehabilitation interventions [11], 66 
and Switzerland is not an exception [12]. 67 
Studies assessing changes in dietary behavior after a CVD event and their effect are relatively 68 
scarce [13]. In the EUROASPIRE study, a large study encompassing 24 European countries, most 69 
(>70%) coronary patients reported trying to change their diet by reducing their consumption of salt, 70 
fat and sugar, and by increasing their consumption of fruits and fish [14], a finding also reported 71 
elsewhere [15, 16]. Still, in the EUROASPIRE study, almost half of obese patients had not followed 72 
dietary recommendations since their coronary event and the smoking rate remained high [14]. 73 
Further, no significant improvement in smoking and a 7% increase in obesity levels was found 74 
between 1999 and 2013 [17]. Noteworthy, no information on dietary intake was available. 75 
Thus, we aimed to compare the dietary intake between subjects who presented with a non-76 
fatal CAD event and gender- and age-matched controls using data from the CoLaus study. Our 77 
hypothesis was that, despite a serious and life-threatening event, no changes in dietary intake would 78 
occur. 79 
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MATERIALS AND METHODS 80 
Participants 81 
The CoLaus study is a population-based study assessing the clinical, biological and genetic 82 
determinants of cardiovascular disease in the city of Lausanne, Switzerland. Its aims and sampling 83 
strategy have been reported previously [18]. 84 
Recruitment began in June 2003 and ended in May 2006, enrolling 6733 total participants 85 
who underwent an interview, a physical exam, and a blood analysis. The first follow-up was 86 
performed between April 2009 and September 2012, 5.6 years on average after the collection of 87 
baseline data; the second follow-up was performed between May 2014 and April 2017, 10.9 years on 88 
average after the collection of baseline data. The information collected was similar to that collected 89 
in the baseline examination, except that dietary assessment was also performed. Hence, for this 90 
study, only data from the follow-up examinations was used. 91 
Dietary intake 92 
Dietary intake of the previous 4 weeks was assessed using a validated, self-administered, 93 
semi-quantitative FFQ that also included portion size [19]. This FFQ consists of 97 different food 94 
items that account for more than 90% of the intake of calories, proteins, fat, carbohydrates, alcohol, 95 
cholesterol, vitamin D and retinol, and 85% of fibre, carotene and iron. For each item, consumption 96 
frequencies ranging from “less than once during the last 4 weeks” to “2 or more times per day” were 97 
provided, and the participants indicated the average serving size (smaller, equal or bigger) compared 98 
to a reference size. Each participant brought along her/his filled-in FFQ, which was checked for 99 
completion by trained interviewers the day of the visit. 100 
Three dietary scores were computed, two based on the Mediterranean diet, the third on a 101 
modification of the alternative healthy eating index (AHEI). The first Mediterranean dietary score 102 
(hereby designated as “Mediterranean score 1”) was derived from Trichopoulou et al. [20], the score 103 
ranges between zero and eight. The second Mediterranean dietary score (hereby designated as 104 
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“Mediterranean score 2”) is adapted to the Swiss population and was computed according to 105 
Vormund et al. [21]. Contrary to the score from Trichopoulou et al, dairy products are considered as 106 
beneficial. The score thus ranges between zero and nine. The AHEI was adapted from McCullough et 107 
al. [22]. In our study, the amount of trans fat could not be assessed, and we considered all 108 
participants taking multivitamins as taking them for a duration ≥5 years. Thus, the modified AHEI 109 
score ranged between 2.5 and 77.5 instead of 2.5 and 87.5 for the original AHEI score [22]. For all 110 
three scores, higher values represented a healthier diet. 111 
Naïve dietary patterns were derived using principal components analysis (PCA) based on 112 
food consumption frequencies. Three dietary patterns were identified: “Meat & fries”, “Fruits & 113 
Vegetables” and “Fatty & sugary”. Detailed description of assessment and characteristics of the 114 
dietary patterns is provided elsewhere [23]. 115 
Participants were dichotomized according to whether they followed the dietary 116 
recommendations for fruits, vegetables, meat, fish and dairy products from the Swiss Society of 117 
Nutrition [24]. The recommendations were ≥2 fruit portions/day; ≥3 vegetable portions/day; ≤5 meat 118 
portions/week; ≥1 fish portion/week and ≥3 dairy products portions/day. As the FFQ queried about 119 
fresh and fried fish, two categories were considered: one included and one excluded fried fish. 120 
Participants were further dichotomized if they complied with at least three recommendations or not; 121 
two categories of compliance to at least three recommendations were created, depending on the 122 
type of fish consumed (all or fresh only). 123 
Presence of an on-going diet was assessed by questionnaire. Diets a) to reduce; b) low in fat; 124 
c) low in sugar / for diabetes, and d) low in salt were considered. 125 
Coronary artery disease 126 
Prevalent and incident coronary artery events were recorded through a stepwise process. 127 
Firstly, relevant medical records were collected in participants who declared, during the baseline 128 
and/or follow-up examinations, to have presented a CVD and/or CVD-related procedure during their 129 
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lifetime, including MI, angina pectoris, stroke, arrhythmia, cardiomyopathy, coronarography and/or 130 
percutaneous transluminal coronary angioplasty (PCA) and/or coronary stenting, and coronary artery 131 
bypass grafting (CABG). The records were collected from general practitioners, cardiologists, 132 
neurologists and/or hospitals (as appropriate), and encompassed medical and/or surgical notes, 133 
laboratory, radiological, echocardiographic and electrocardiographic reports. If necessary, the 134 
original coronarography (angiogram) and brain CT/MRI exams were collected. Secondly, to retrieve 135 
events that may not have been mentioned during interviews, we searched the central medical 136 
database of the University Hospital of Lausanne, which corresponds to the main community hospital 137 
in the catchment area of the study. Participants with hospital records were identified cross-checking 138 
with administrative data and events of interest were detected using the following ICD-10 139 
(International Classification of diseases, Tenth Edition) codes: I20.0, I21.-, I22.-, I24.-, I25.1-, I25.2-, 140 
I25.5, I25.6, I25.8, I25.9, I61.-, I62.-, I63.-, I64, I69.1, I69.2, I69.3, I69.4, I69.8, and G45.-. Thirdly, death 141 
was established using the population register of the city where the participant was living in case of 142 
returned mail, absence of response when calling and/or indication from a relative. Information on its 143 
cause was in order and selectively collected from: 1) general practitioners; 2) medical database of the 144 
hospital where the death occurred (either in Switzerland or abroad); 3) database of the pre-hospital 145 
emergency care unit of the City of Lausanne; 4) database of the University Centre of Legal Medicine 146 
of Lausanne and Geneva; 5) official death certificates from the Swiss governmental agency providing 147 
death statistics; 6) verbal autopsy with a relative of the dead participant, if all previous steps failed. 148 
Non-fatal MI and other coronary artery disease (CAD) were adjudicated by two cardiologists 149 
based mainly upon an international expert consensus document [25]. Unstable angina (UA) was 150 
included into MI category in order to correspond with the clinical ‘acute coronary syndrome’ entity. 151 
Diagnosis of UA was based upon the record of a consultation (either outpatient or inpatient) for 152 
worsening symptoms and resulting in a change in antianginal medication, unless troponin values 153 
were positive. CAD corresponded to subjects who presented typical symptoms (stable angina) and 154 
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underwent either percutaneous (PCA ± stenting) or surgical (CABG) revascularizations, unless these 155 
procedures were directly related to a MI. 156 
History of coronary artery disease at first follow-up was defined as incident cases of CAD 157 
between baseline and follow-up and previous history of CAD. Incident cases were defined as an 158 
event that occurred between the first and the second follow-up. 159 
Covariates 160 
Smoking status (never smokers, ex-smokers, current smokers) was self-reported. Marital 161 
status was categorized as living alone (i.e. being single, divorced and widowed) or in couple (i.e. 162 
married or cohabiting). Educational level was categorized as high (university), middle (high school) 163 
and low (apprenticeship and mandatory). Participants indicated which medicines they were currently 164 
taking, and the following dichotomous categories were created: antihypertensives, hypolipidemics 165 
and antidiabetics. 166 
Body weight and height were measured with participants barefoot and in light indoor 167 
clothes. Body weight was measured in kilograms to the nearest 100 g using a Seca® scale (Hamburg, 168 
Germany). Height was measured to the nearest 5 mm using a Seca® (Hamburg, Germany) height 169 
gauge. Body mass index (BMI) was computed and categorized into normal (<25 kg/m2), overweight 170 
(25-29.9 kg/m2) and obese (≥30 kg/m2). 171 
Matching 172 
Matching was performed on gender and age using the rangejoin command of Stata. A first 173 
matching was performed using a ±1 year constraint. If no controls could be found, the constraint 174 
was relaxed to ±2 years. 175 
Statistical analysis 176 
Three analyses were performed. The first analysis compared dietary intake at first follow-up 177 
between participants with history of CAD and gender- and age-matched controls. The second 178 
analysis compared dietary intake at second follow-up between participants who presented with an 179 
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incident CAD event between the first and the second follow-up and gender- and age-matched 180 
controls devoid of history of CAD. The third analysis compared dietary markers at first and second 181 
follow-up among participants who presented with an incident CAD event.  182 
Statistical analyses were performed using Stata version 15.1 for windows (Stata Corp, College 183 
Station, Texas, USA). Descriptive results were expressed as number of participants (percentage) for 184 
categorical variables or as average standard deviation for continuous variables. For the first and 185 
second analyses, bivariate comparisons between cases and controls were performed using chi-186 
square or Fisher’s exact test for qualitative variables and Student’s t-test for continuous variables. 187 
Multivariate analyses were performed using conditional logistic regression for categorical variables 188 
and the results were expressed as Odds ratio (OR) and 95% confidence interval (CI); for continuous 189 
variables, multivariable analyses were performed using a mixed model were the matching group was 190 
included in the random part of the model; variable to adjust for were selected based on previous 191 
literature and univariate analyses. Multivariable models were adjusted for living in couple (yes, no), 192 
educational level (high, middle, low), body mass index (normal, overweight, obese), smoking (never, 193 
former, current), and antihypertensive, hypolipidemic and antidiabetic drug treatments. 194 
For the third analyses, exact Mc Nemar’s test for categorical variables and paired student’s t-195 
test for continuous variables were used. Due to the number of tests performed, statistical 196 
significance was assessed for a two-sided test with p<0.005. 197 
Exclusion criteria 198 
For the first analysis, participants were excluded if they 1) lacked dietary information; 2) had 199 
a total energy intake (TEI) <850 or >4500 kcal/day; 3) lacked any covariate and 4) could not be 200 
matched (for participants with CAD). For the second analysis, participants were excluded if they 1) 201 
had no follow-up; 2) lacked dietary information; 3) had a total energy intake (TEI) <850 or >4500 202 
kcal/day; 4) lacked any covariate and 5) had a previous history of CAD (for participants without 203 
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incident CAD). For the third analysis, participants were excluded if they 1) lacked dietary information; 204 
2) had a total energy intake (TEI) <850 or >4500 kcal/day at first or second follow-ups. 205 
Ethical statement 206 
The institutional Ethics Committee of the University of Lausanne, which afterwards became 207 
the Ethics Commission of Canton Vaud (www.cer-vd.ch) approved the baseline CoLaus study 208 
(reference 16/03, decisions of 13th January and 10th February 2003); the approval was renewed for 209 
the first (reference 33/09, decision of 23rd February 2009) and the second (reference 26/14, decision 210 
of 11th March 2014) follow-up. All participants gave their signed informed consent before entering 211 
the study. 212 
RESULTS 213 
Characteristics of participants 214 
The selection procedure of the participants for the first and the second analyses is provided 215 
in supplementary figures 1 and 2. The socio-demographic and clinical characteristics of cases and 216 
controls for the first analysis is provided in table 1 and for second analysis in supplementary table 1. 217 
For the first analysis, cases tended to be slightly older, had a lower educational level, a higher BMI, a 218 
higher prevalence of former smokers, and a higher prevalence of antihypertensive, hypolipidemic 219 
and antidiabetic drugs than controls (Table 1). For the second analysis, cases had a higher prevalence 220 
of antihypertensive and hypolipidemic drugs than controls, while no differences were found for all 221 
other variables studied (Supplementary table 1). 222 
223 
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 224 
 Controls Cases P-value 
Sample size 661 356  
Women (%) 277 (41.9) 148 (41.6) 0.918 
Age (years) 65.0 ± 9.3 66.2 ± 9.2 0.052 
Living in couple (%) 418 (63.2) 210 (59.0) 0.184 
Educational level (%)   <0.001 
High 117 (17.7) 43 (12.1)  
Middle 206 (31.2) 78 (21.9)  
Low 338 (51.1) 235 (66.0)  
Body mass index 26.1 ± 4.2 27.7 ± 4.8 <0.001 
Body mass index categories (%)   <0.001 
Normal 275 (41.6) 103 (28.9)  
Overweight 288 (43.6) 160 (44.9)  
Obese 98 (14.8) 93 (26.1)  
Smoking status (%)   0.001 
Never 286 (43.3) 112 (31.5)  
Former 264 (39.9) 183 (51.4)  
Current 111 (16.8) 61 (17.1)  
Treatments (%)    
Antihypertensive 223 (33.7) 249 (69.9) <0.001 
Hypolipidemic 146 (22.1) 211 (59.3) <0.001 
Antidiabetic 50 (7.6) 53 (14.9) <0.001 
Table 1: socio-demographic and clinical characteristics of participants with history of coronary heart 225 
disease and gender- and age-matched controls, CoLaus study, Lausanne, Switzerland. 226 
Results are expressed as number (percentage) for categorical variables or as average ± standard 227 
deviation for continuous variables. Between-group comparisons were performed using chi-square for 228 
categorical variables and student’s t-test for continuous variables. 229 
230 
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Dietary intake among participants with history of coronary artery disease 231 
Dietary intake among participants with history of CAD and gender- and age-matched controls 232 
is summarized in tables 2 (bivariate) and 3 (multivariable). On bivariate analysis, cases had a lower 233 
total energy intake and lower levels of the Mediterranean dietary score, the AHEI and the “Fruits & 234 
Vegetables” dietary pattern than controls; conversely, cases had a higher prevalence of low fat and 235 
low sugar/diabetic diets and scored less than controls in the “Pastries & fat” dietary pattern (Table 236 
2). After multivariable analysis, cases had a lower total energy intake than controls, while no 237 
difference was found for all other dietary markers (Table 3). 238 
239 
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 240 
 Controls Cases P-value 
Sample size N=661 N=356  
Total energy intake (kcalories/day) 1946 ± 643 1821 ± 634 0.003 
Macronutrients (% TEI)    
Total protein 15.0 ± 2.9 15.0 ± 2.9 0.663 
Vegetable protein 4.7 ± 1.2 4.8 ± 1.3 0.812 
Animal protein 10.2 ± 3.3 10.3 ± 3.3 0.765 
Total carbohydrates 46.6 ± 8.9 47.1 ± 9.6 0.407 
Monosaccharides 22.9 ± 8.0 23.2 ± 9.1 0.633 
Polysaccharides 23.5 ± 7.7 23.8 ± 8.8 0.627 
Total fat 33.9 ± 6.8 33.1 ± 7.0 0.080 
Saturated 12.7 ± 3.5 12.3 ± 3.6 0.055 
Monounsaturated 13.4 ± 3.5 13.0 ± 3.5 0.159 
Polyunsaturated 4.8 ± 1.6 4.9 ± 1.6 0.719 
Dietary scores    
Mediterranean § 4.1 ± 1.5 4.1 ± 1.5 0.515 
Mediterranean §§ 4.8 ± 1.8 4.5 ± 2.0 0.019 
AHEI 33 ± 10 31 ± 10 0.011 
Dietary patterns N=630 N=327  
Meat & Chips -0.07 ± 1.09 -0.06 ± 1.16 0.866 
Fruits & Vegetables 0.07 ± 1.61 -0.18 ± 1.56 0.022 
Pastries & Fat 0.19 ± 1.42 -0.06 ± 1.37 0.009 
Compliance to dietary guidelines N=661 N=356  
Fruits 323 (48.9) 160 (44.9) 0.232 
Vegetables 50 (7.6) 27 (7.6) 0.991 
Meat 413 (62.5) 230 (64.6) 0.503 
Fish 435 (65.8) 245 (68.8) 0.331 
Fish § 264 (39.9) 127 (35.7) 0.182 
Dairy 62 (9.4) 24 (6.7) 0.149 
At least three 184 (27.8) 94 (26.4) 0.625 
At least three § 133 (20.1) 63 (17.7) 0.350 
Presence of a diet    
To reduce 42 (6.4) 18 (5.1) 0.402 
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Low fat 144 (21.8) 117 (32.9) <0.001 
Low sugar / for diabetes 52 (7.9) 55 (15.5) <0.001 
Low salt 34 (5.1) 28 (7.9) 0.084 
Table 2: bivariate analysis of dietary intake between participants with history of coronary heart 241 
disease and gender- and age-matched controls, CoLaus study, Lausanne, Switzerland  242 
TEI, total energy intake. §, excluding fried fish. Results are expressed as number (percentage) for 243 
categorical variables or as average ± standard deviation for continuous variables. Between-group 244 
comparisons were performed using chi-square for categorical variables and student’s t-test for 245 
continuous variables. 246 
247 
14 
 
 248 
 Controls Cases P-value 
Sample size N=661 N=356  
Total energy intake (kcalories/day) 1940 ± 26 1833 ± 36 0.022 
Macronutrients (% TEI)    
Total protein 14.9 ± 0.1 15.1 ± 0.2 0.337 
Vegetable protein 4.7 ± 0.1 4.8 ± 0.1 0.341 
Animal protein 10.2 ± 0.1 10.3 ± 0.2 0.624 
Total carbohydrates 46.5 ± 0.4 47.2 ± 0.5 0.284 
Monosaccharides 22.9 ± 0.4 23.3 ± 0.5 0.464 
Polysaccharides 23.5 ± 0.3 23.8 ± 0.5 0.600 
Total fat 33.7 ± 0.3 33.4 ± 0.4 0.513 
Saturated 12.7 ± 0.1 12.4 ± 0.2 0.259 
Monounsaturated 13.3 ± 0.1 13.2 ± 0.2 0.654 
Polyunsaturated 4.8 ± 0.1 4.8 ± 0.1 0.982 
Dietary scores    
Mediterranean § 4.1 ± 0.1 4.1 ± 0.1 0.738 
Mediterranean §§ 4.8 ± 0.1 4.6 ± 0.1 0.127 
AHEI 32 ± 1 32 ± 1 0.285 
Dietary patterns N=630 N=327  
Meat & Chips -0.06 ± 0.05 -0.08 ± 0.07 0.818 
Fruits & Vegetables 0.03 ± 0.07 -0.08 ± 0.09 0.349 
Pastries & Fat 0.17 ± 0.06 -0.01 ± 0.08 0.095 
Compliance to dietary guidelines N=661 N=356  
Fruits 1 (ref.) 0.99 (0.72 - 1.37) 0.948 
Vegetables 1 (ref.) 0.84 (0.46 - 1.54) 0.581 
Meat 1 (ref.) 1.02 (0.73 - 1.41) 0.923 
Fish 1 (ref.) 1.31 (0.93 - 1.86) 0.121 
Fish § 1 (ref.) 0.93 (0.66 - 1.30) 0.654 
Dairy 1 (ref.) 0.88 (0.50 - 1.54) 0.647 
At least three 1 (ref.) 1.14 (0.77 - 1.67) 0.519 
At least three § 1 (ref.) 0.98 (0.65 - 1.49) 0.941 
Presence of a diet    
To reduce 1 (ref.) 0.59 (0.26 - 1.32) 0.196 
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Low fat 1 (ref.) 1.19 (0.83 - 1.70) 0.337 
Low sugar / for diabetes 1 (ref.) 1.86 (0.82 - 4.19) 0.135 
Low salt 1 (ref.) 1.45 (0.77 - 2.75) 0.251 
Table 3: multivariable analysis of dietary intake between participants with history of coronary heart 249 
disease and gender- and age-matched controls, CoLaus study, Lausanne, Switzerland. 250 
TEI, total energy intake. §, excluding fried fish. Results are expressed as multivariable adjusted odds 251 
ratio and (95% confidence interval) for categorical variables and as multivariable adjusted 252 
mean±standard error. Between-group comparisons were performed using conditional logistic 253 
regression for categorical variables and a mixed model for continuous variables. All models were 254 
adjusted for living in couple (yes, no), educational level (high, middle, low), body mass index (normal, 255 
overweight, obese), smoking (never, former, current), and antihypertensive, hypolipidemic and 256 
antidiabetic drug treatments. 257 
 258 
 259 
Dietary intake among participants with incident coronary artery disease 260 
Eighty-seven participants developed a CAD event between the first and the second follow-up. 261 
Their dietary intake before and after the occurrence of the event is summarized in table 4. Total 262 
energy intake increased slightly and prevalence of low fat diet decreased, while no difference was 263 
found for all other dietary markers. 264 
265 
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 266 
 Before After P-value 
Total energy intake (kcalories/day) 1927 ± 593 2100 ± 700 0.029 
Macronutrients (% TEI)    
Total protein 14.8 ± 2.6 15.2 ± 3.8 0.390 
Vegetable protein 4.8 ± 1.2 4.8 ± 1.3 0.977 
Animal protein 10.1 ± 2.9 10.4 ± 4.3 0.461 
Total carbohydrates 45.8 ± 9.2 46.1 ± 10.6 0.780 
Monosaccharides 21.7 ± 7.5 22.2 ± 9.9 0.599 
Polysaccharides 24.0 ± 7.8 23.8 ± 8.7 0.804 
Total fat 34.0 ± 6.4 34.2 ± 7.9 0.753 
Saturated 12.9 ± 3.4 12.9 ± 4.1 0.952 
Monounsaturated 13.3 ± 3.3 13.6 ± 4.2 0.502 
Polyunsaturated 4.9 ± 1.4 4.8 ± 1.5 0.356 
Dietary scores    
Mediterranean § (N=79) 4.2 ± 1.5 4.0 ± 1.6 0.504 
Mediterranean §§ (N=60) 5.0 ± 2.0 4.9 ± 2.0 0.715 
AHEI (N=80) 32 ± 11 34 ± 9 0.198 
Compliance to dietary guidelines    
Fruits 40.5 (29.9 - 51.7) 52.4 (41.2 - 63.4) 0.064 
Vegetables 9.5 (4.2 - 17.9) 15.5 (8.5 - 25.0) 0.227 
Meat 59.5 (48.3 - 70.1) 50.0 (38.9 - 61.1) 0.185 
Fish 68.2 (57.2 - 77.9) 75.3 (64.7 - 84.0) 0.345 
Fish § 36.5 (26.3 - 47.6) 43.5 (32.8 - 54.7) 0.286 
Dairy 4.8 (1.3 - 11.9) 12.0 (5.9 - 21.0) 0.146 
At least three 24.1 (15.4 - 34.7) 28.9 (19.5 - 39.9) 0.481 
At least three § 19.3 (11.4 - 29.4) 22.9 (14.4 - 33.4) 0.549 
Presence of a diet    
To reduce 5.7 (1.9 - 12.9) 6.9 (2.6 - 14.4) 1.000 
Low fat 35.6 (25.6 - 46.6) 21.8 (13.7 - 32.0) 0.036 
Low sugar / for diabetes 13.8 (7.3 - 22.9) 8.0 (3.3 - 15.9) 0.267 
Low salt 6.9 (2.6 - 14.4) 5.7 (1.9 - 12.9) 1.000 
Table 4: paired analysis of the dietary intake of participants who developed coronary heart disease 267 
between first and second follow-up, CoLaus study, Lausanne, Switzerland (n=87).  268 
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Results are expressed as percentage (95% confidence interval) for categorical variables or as average 269 
± standard deviation for continuous variables. Between-group comparisons were performed using 270 
exact Mc Nemar’s test for categorical variables and paired student’s t-test for continuous variables. 271 
 272 
Changes in dietary intake among participants with incident coronary artery disease 273 
Dietary intake at second follow-up among participants with incident CAD and gender- and 274 
age-matched controls is summarized in supplementary tables 2 (bivariate) and 3 (multivariable). On 275 
bivariate analysis, participants with incident CAD had higher vegetable protein intake, a higher AHEI 276 
score, complied more frequently with vegetables guidelines and reported more frequently a diet to 277 
reduce or a low-fat diet than controls (supplementary table 2). Those differences remained after 278 
multivariable adjustment except for diet, for which the multivariable models did not converge 279 
(supplementary table 3). 280 
DISCUSSION 281 
 In agreement with our initial hypothesis, the results indicate that, despite a serious and life-282 
threatening event such as CAD, no substantial changes in dietary intake occur after a coronary event. 283 
Our findings add further evidence to the lack of adequate dietary prevention of subsequent 284 
cardiovascular events. 285 
Dietary intake among participants with history of coronary artery disease 286 
Participants with history of CAD did not differ from participants devoid of CAD regarding all 287 
dietary markers. The sole exception was a reduced total energy intake, which remained statistically 288 
significant after multivariable analysis. Still, the absolute difference was small (approximately 100 289 
kcal/day) and could be accounted for by a reporting bias. As participants with history of CAD were 290 
more frequently obese, it is possible that they have (un)voluntarily underreported their true dietary 291 
intake. A possible explanation for the lack of difference regarding dietary intake between participants 292 
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with history of CAD and participants devoid of CAD could be the difficulty for the first to put into 293 
practice the dietary information received during rehabilitation [26].  294 
Dietary intake among participants with incident coronary artery disease 295 
In a previous study, we have shown that participants reporting a low-fat diet have a healthier 296 
dietary intake than the general population [27]. Hence, it is likely that higher prevalence of a low-fat 297 
diet among participants with incident CAD would explain the higher intake of vegetables, vegetable 298 
proteins and the higher AHEI score in this group relative to gender- and age-matched controls. Still, 299 
dietary intake of participants with incident CAD differed little from controls, suggesting that the 300 
changes were modest and likely insufficient to adequately prevent CAD recurrence. Although the 301 
compliance to dietary guidelines was relatively low, still it was comparable or event better than 302 
reported by an Italian study conducted in patients with acute myocardial infarction [28]: 7.6% vs. 303 
7.7% for vegetables and 68.8% vs. 18.5% for fish. Still, our results show that dietary intake of subjects 304 
with CAD is suboptimal and could be improved. 305 
Changes in dietary intake among participants with incident coronary artery disease 306 
There are few studies assessing dietary intake before and after a CAD event. In this study, 307 
almost no changes in dietary intake were found after the occurrence of a CAD event. Although the 308 
sample size was small (n=87) and might have reduced statistical power, still the changes observed 309 
were extremely small and clinically meaningless. For instance, the small increase in total energy 310 
intake (+173 kcal/day) after the CAD event could have been due to a better knowledge of the FFQ by 311 
the participants, making them report more accurately their dietary intake. Similarly, although the 312 
compliance regarding most foods tended to increase, still less than one third of participants complied 313 
with at least three recommendations after the event. 314 
The prevalence of diets aimed at reducing cardiovascular risk factors was considerably lower 315 
than reported in other studies such as EUROASPIRE [14]: 6.9% vs. 63.3% to reduce weight, 21.8% vs. 316 
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78.9% to reduce fat, 8.0% vs. 66.1% to reduce sugar and 5.7% vs. 71.8% (and 29.6% in a French study 317 
[29]) to reduce salt. More worryingly, the prevalence of a low-fat diet decreased after the event, 318 
suggesting a possible shift towards lipid-lowering drug therapies. Again, our results show that the 319 
occurrence of a CAD does not lead to an improvement in dietary intake. Future studies focusing on a 320 
larger sample size and a larger panel of questions should identify the reasons for this failure. 321 
Suggestions for clinical practice and public health 322 
Several interventions to promote dietary prevention of CAD could be implemented. Firstly, 323 
increased training in dietary counselling could be provided during medical training [30], as a previous 324 
study showed that most medical residents in the university hospital of Lausanne lacked training in 325 
dietary information and guidelines [31]. Secondly, dietary management of CAD could be 326 
implemented during cardiovascular rehabilitation; although dietary counselling is already included in 327 
most if not all rehabilitation programs in Switzerland [32], specific methods such as the Health Action 328 
Process Approach [33] have been shown to induce persistent improvements in dietary intake and 329 
could be tested. Given the underuse of cardiac rehabilitation programs in the French-speaking part of 330 
Switzerland [12], a simple increase in the number of patients admitted into rehabilitation might 331 
already be of interest. Thirdly, programs aiming at maintaining a healthy lifestyle could be 332 
implemented among CAD patients, as many CAD patients fail to translate the dietary information 333 
received during rehabilitation into practice after discharge [26]. For instance, nurse-led [34] or 334 
community health-worker [35] based interventions have been shown to be effective in changing 335 
dietary intake, although for the first study no long-term results (>1 year) were reported. Finally, 336 
general campaigns promoting healthy eating would improve dietary intake in the general population 337 
and ipso facto among CAD patients. 338 
Study limitations 339 
Several limitations should be acknowledged. First, the small sample evaluated challenged the 340 
statistical power. Still, the non-significant differences between cases and controls were small and 341 
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clinically meaningless. More importantly, it was the low rate of compliance with guidelines and the 342 
low prevalence of diets among cases that was of concern. Second, the FFQ focused on a limited 343 
number of food items (97); hence, some specific foods such as grains and pulses were not evaluated. 344 
Still, as the FFQ was applied in both cases and controls, we expect that the magnitude of this 345 
reporting bias is the same for both groups. Third, there was little information socio-economic status, 346 
a major determinant of a healthy diet. Indeed, healthy diets tend to be more expensive [36], 347 
although this statement has been challenged [37, 38]. Interestingly, previous studies have shown 348 
that, in Switzerland, the influence of socioeconomic factors on nutrient intake varies according to 349 
gender [39] and that people with a low socio-economic status (i.e. migrants from Southern Europe) 350 
score higher for both healthy (Fruits and vegetables) and unhealthy (Meat and fries) dietary patterns 351 
than people of higher socio-economic status [23]. In this study, we used educational level and marital 352 
status as proxies for socio-economic status and included them in the multivariable analyses. Still, 353 
further studies should rely on stronger socio-economic markers such as personal or family income to 354 
better assess this issue. Finally, no information regarding rehabilitation post CAD was collected, and 355 
it has been suggested that rehabilitation improves dietary intake [40], although this statement has 356 
been challenged [26]. Further, use of cardiac rehabilitation programs in the French-speaking part of 357 
Switzerland is rather low [12]; hence, their impact on diet might be also low. Finally, the results were 358 
obtained from participants living in the city of Lausanne, and its generalizability to other Swiss 359 
cantons or other countries might be questionable. Still, in the absence of other studies conducted in 360 
Switzerland, our findings represent a first step in the evaluation of lifestyle management of CAD in 361 
Switzerland. Our findings also suggest that the actual lifestyle management of CAD in the general 362 
population might be worse than previously reported [14]. 363 
We conclude that in Switzerland, adequate improvements in diet for secondary prevention of 364 
CAD is suboptimal and require further attention. Supporting patients to improve their dietary intake 365 
via behaviour changing therapy is recommended. 366 
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FIGURE LEGENDS 501 
Supplementary figure 1: selection procedure of the cases and gender- and age-matched controls for 502 
the first analysis, CoLaus study, Lausanne, Switzerland. 503 
Supplementary figure 2: selection procedure of the cases and gender- and age-matched controls for 504 
the second analysis, CoLaus study, Lausanne, Switzerland. 505 
 506 
507 
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SUPPLEMENTARY FILES 508 
Supplementary table 1: socio-demographic and clinical characteristics of participants with incident 509 
coronary heart disease and gender- and age-matched controls, CoLaus study, Lausanne, Switzerland. 510 
 511 
 Controls Cases P-value 
Sample size 181 92  
Women (%) 46 (25.4) 23 (25.0) 0.941 
Age (years) 64.4 ± 9.3 65.5 ± 9.2 0.340 
Living in couple (%) 121 (66.9) 57 (62.0) 0.422 
Educational level (%)   0.894 
High 37 (20.4) 18 (19.6)  
Middle 53 (29.3) 25 (27.2)  
Low 91 (50.3) 49 (53.3)  
Body mass index 26.0 ± 3.7 26.8 ± 3.8 0.103 
Body mass index categories (%)   0.152 
Normal 81 (44.8) 30 (32.6)  
Overweight 76 (42.0) 48 (52.2)  
Obese 24 (13.3) 14 (15.2)  
Smoking status (%)   0.313 
Never 68 (37.6) 33 (35.9)  
Former 85 (47.0) 38 (41.3)  
Current 28 (15.5) 21 (22.8)  
Treatments (%)    
Antihypertensive 58 (32.0) 48 (52.2) <0.001 
Hypolipidemic 36 (19.9) 46 (50.0) <0.001 
Antidiabetic 17 (9.4) 11 (12.0) 0.509 
Results are expressed as number (percentage) for categorical variables or as average ± standard 512 
deviation for continuous variables. Between-group comparisons were performed using chi-square for 513 
categorical variables and student’s t-test for continuous variables. 514 
 515 
516 
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Supplementary table 2: bivariate analysis of dietary intake between participants with incident 517 
coronary heart disease and gender- and age-matched controls, CoLaus study, Lausanne, Switzerland 518 
 Controls Cases P-value 
Sample size 181 92  
Total energy intake (kcalories/day) 2047 ± 660 2037 ± 697 0.911 
Macronutrients (% TEI)    
Total protein 15.4 ± 2.7 15.3 ± 3.9 0.794 
Vegetable protein 4.5 ± 1.1 4.8 ± 1.2 0.050 
Animal protein 11 ± 3.1 10.6 ± 4.5 0.393 
Total carbohydrates 44.9 ± 8.4 46.2 ± 10.6 0.248 
Monosaccharides 21.9 ± 8 22.0 ± 9.7 0.885 
Polysaccharides 22.9 ± 7.8 24.1 ± 8.7 0.234 
Total fat 34.9 ± 6.7 33.9 ± 7.8 0.250 
Saturated 13.4 ± 3.4 12.6 ± 3.9 0.080 
Monounsaturated 13.9 ± 3.6 13.6 ± 4.2 0.507 
Polyunsaturated 4.6 ± 1.3 4.8 ± 1.5 0.416 
Dietary scores    
Mediterranean § 3.9 ± 1.5 4.0 ± 1.6 0.701 
Mediterranean §§ 4.8 ± 2.2 4.9 ± 2.0 0.863 
AHEI 31 ± 9 34 ± 9 0.040 
Compliance to dietary guidelines    
Fruits 86 (48.3) 44 (49.4) 0.865 
Vegetables 14 (7.9) 14 (15.7) 0.048 
Meat 83 (46.9) 45 (50.6) 0.572 
Fish 130 (73.0) 66 (73.3) 0.958 
Fish § 86 (48.3) 40 (44.4) 0.549 
Dairy 20 (11.3) 11 (12.5) 0.775 
At least three 48 (27.1) 24 (27.3) 0.979 
At least three § 37 (20.9) 18 (20.5) 0.932 
Presence of a diet    
To reduce 4 (2.2) 7 (7.6) 0.048 † 
Low fat 12 (6.6) 23 (25.0) <0.001 † 
Low sugar / for diabetes 8 (4.4) 8 (8.7) 0.177 † 
Low salt 4 (2.2) 5 (5.4) 0.170 † 
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TEI, total energy intake. §, excluding fried fish. Results are expressed as number (percentage) for 519 
categorical variables or as average ± standard deviation for continuous variables. Between-group 520 
comparisons were performed using chi-square or Fisher’s exact test (†) for categorical variables and 521 
student’s t-test for continuous variables. 522 
523 
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Supplementary table 3: multivariable analysis of dietary intake between participants with incident 524 
coronary heart disease and gender- and age-matched controls, CoLaus study, Lausanne, Switzerland. 525 
 Controls Cases P-value 
Sample size 181 92  
Total energy intake (kcalories/day) 2027 ± 52 2078 ± 72 0.559 
Macronutrients (% TEI)    
Total protein 15.5 ± 0.2 15.2 ± 0.3 0.426 
Vegetable protein 4.5 ± 0.1 4.8 ± 0.1 0.028 
Animal protein 11.1 ± 0.3 10.4 ± 0.4 0.170 
Total carbohydrates 44.8 ± 0.7 46.3 ± 1 0.212 
Monosaccharides 22 ± 0.7 21.8 ± 0.9 0.848 
Polysaccharides 22.7 ± 0.6 24.4 ± 0.9 0.095 
Total fat 34.7 ± 0.5 34.3 ± 0.8 0.677 
Saturated 13.3 ± 0.3 12.9 ± 0.4 0.356 
Monounsaturated 13.9 ± 0.3 13.7 ± 0.4 0.813 
Polyunsaturated 4.6 ± 0.1 4.8 ± 0.1 0.275 
Dietary scores    
Mediterranean § 3.8 ± 0.1 4.1 ± 0.2 0.249 
Mediterranean §§ 4.8 ± 0.2 4.9 ± 0.3 0.675 
AHEI 31 ± 1 34 ± 1 0.032 
Compliance to dietary guidelines    
Fruits 1 (ref.) 1.23 (0.65 - 2.33) 0.516 
Vegetables 1 (ref.) 7.64 (1.06 - 55.2) 0.044 
Meat 1 (ref.) 1.49 (0.81 - 2.77) 0.202 
Fish 1 (ref.) 1.06 (0.55 - 2.04) 0.873 
Fish § 1 (ref.) 0.76 (0.41 - 1.43) 0.399 
Dairy 1 (ref.) 1.53 (0.57 - 4.08) 0.398 
At least three 1 (ref.) 1.26 (0.61 - 2.62) 0.536 
At least three § 1 (ref.) 1.13 (0.51 - 2.48) 0.767 
TEI, total energy intake. §, excluding fried fish. Results are expressed as multivariable adjusted odds 526 
ratio and (95% confidence interval) for categorical variables and as multivariable adjusted 527 
mean±standard error. Between-group comparisons were performed using conditional logistic 528 
regression for categorical variables and a mixed model for continuous variables. All models were 529 
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adjusted for living in couple (yes, no), educational level (high, middle, low), body mass index (normal, 530 
overweight, obese), smoking (never, former, current), and antihypertensive, hypolipidemic and 531 
antidiabetic drug treatments. For diets, the model did not converge and results are not presented. 532 
 533 
